{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T02:08:30Z","timestamp":1782785310144,"version":"3.54.5"},"reference-count":107,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901219"],"award-info":[{"award-number":["81901219"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071330"],"award-info":[{"award-number":["82071330"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>Myelin oligodendrocyte glycoprotein-IgG-associated disorder (MOGAD) is a nervous system (NS) demyelination disease and a newly recognized distinct disease complicated with various diseases or symptoms; however, MOGAD was once considered a subset of neuromyelitis optica spectrum disorder (NMOSD). The detection of MOG-IgG has been greatly improved by the cell-based assay test method. In one study, 31% of NMOSD patients with negative aquaporin-4 (AQP-4) antibody were MOG-IgG positive. MOGAD occurs in approximately the fourth decade of a person\u2019s life without a markedly female predominance. Usually, optic neuritis (ON), myelitis or acute disseminated encephalomyelitis (ADEM) encephalitis are the typical symptoms of MOGAD. MOG-IgG have been found in patients with peripheral neuropathy, teratoma, COVID-19 pneumonia, etc. Some studies have revealed the presence of brainstem lesions, encephalopathy or cortical encephalitis. Attention should be given to screening patients with atypical symptoms. Compared to NMOSD, MOGAD generally responds well to immunotherapy and has a good functional prognosis. Approximately 44-83% of patients undergo relapsing episodes within 8 months, which mostly involve the optic nerve, and persistently observed MOG-IgG and severe clinical performance may indicate a polyphasic course of illness. Currently, there is a lack of clinical randomized controlled trials on the treatment and prognosis of MOGAD. The purpose of this review is to discuss the clinical manifestations, imaging features, outcomes and prognosis of MOGAD.<\/jats:p>","DOI":"10.3389\/fnagi.2022.850743","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T09:18:04Z","timestamp":1647335884000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinical Features and Imaging Findings of Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disorder (MOGAD)"],"prefix":"10.3389","volume":"14","author":[{"given":"Yunjie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2018.10.016","article-title":"Clinical spectrum of inflammatory central nervous system demyelinating disorders associated with antibodies against myelin oligodendrocyte glycoprotein.","volume":"130","author":"Akaishi","year":"2019","journal-title":"Neurochem. Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1212\/WNL.0000000000012175","article-title":"Difference in the source of Anti-AQP4-IgG and Anti-MOG-IgG antibodies in CSF in patients with neuromyelitis optica spectrum disorder.","volume":"97","author":"Akaishi","year":"2021","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1007\/s10072-020-04343-3","article-title":"Cerebrospinal fluid MOG-antibodies in anti-NMDA receptor encephalitis with leptomeningeal enhancement.","volume":"41","author":"Amano","year":"2020","journal-title":"Neurol. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000002125","article-title":"Autoimmune post-herpes simplex encephalitis of adults and teenagers.","volume":"85","author":"Armangue","year":"2015","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/jnnp-2014-308346","article-title":"Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.","volume":"86","author":"Baumann","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s001090050092","article-title":"Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis.","volume":"75","author":"Bernard","year":"1997","journal-title":"J. Mol. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1007\/s00415-017-8615-8","article-title":"Optic neuritis in patients with anti-MOG antibodies spectrum disorder: MRI and clinical features from a large multicentric cohort in France.","volume":"264","author":"Biotti","year":"2017","journal-title":"J. Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.msard.2019.05.021","article-title":"MOG antibody-associated demyelinating disease mimicking typical multiple sclerosis: a case for expanding anti-MOG testing?","volume":"33","author":"Breza","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"B9","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/ana.21916","article-title":"Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease.","volume":"66","author":"Brilot","year":"2009","journal-title":"Ann. Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ejpn.2020.10.006","article-title":"E.U. paediatric MOG consortium consensus: part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.","volume":"29","author":"Bruijstens","year":"2020","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1007\/s00415-019-09440-8","article-title":"Unilateral cortical FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis with Seizures (FLAMES): characterization of a distinct clinico-radiographic syndrome.","volume":"266","author":"Budhram","year":"2019","journal-title":"J. Neurol."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103118","article-title":"Distinct patterns of MRI lesions in MOG antibody disease and AQP4 NMOSD: a systematic review and meta-analysis.","volume":"54","author":"Carandini","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1007\/s11547-019-01073-1","article-title":"MRI of acute optic neuritis (ON) at the first episode: can we predict the visual outcome and the development of multiple sclerosis (MS)?","volume":"124","author":"Cellina","year":"2019","journal-title":"Radiol. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s13760-020-01356-9","article-title":"Spectrum of anti-myelin oligodendrocyte glycoprotein antibody (MOG-Ab)-associated diseases: an Indian perspective.","volume":"121","author":"Chaudhuri","year":"2021","journal-title":"Acta Neurol. Belg."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1212\/WNL.0000000000009758","article-title":"Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder.","volume":"95","author":"Chen","year":"2020","journal-title":"Neurology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.ejpn.2017.06.002","article-title":"Hashimoto\u2019s encephalopathy and anti-MOG antibody encephalitis: 50 years after Lord Brain\u2019s description.","volume":"21","author":"Chen","year":"2017","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1177\/1352458519849511","article-title":"Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: a retrospective multicentric study.","volume":"26","author":"Ciron","year":"2020","journal-title":"Mult. Scler."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study.","volume":"90","author":"Cobo-Calvo","year":"2018","journal-title":"Neurology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/ana.25909","article-title":"Clinical features and risk of relapse in children and adults with myelin oligodendrocyte glycoprotein antibody-associated disease.","volume":"89","author":"Cobo-Calvo","year":"2021","journal-title":"Ann. Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s00415-017-8583-z","article-title":"MOG antibody-related disorders: common features and uncommon presentations.","volume":"264","author":"Cobo-Calvo","year":"2017","journal-title":"J. Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/dmcn.14594","article-title":"Risk factors for academic difficulties in children with myelin oligodendrocyte glycoprotein antibody-associated acute demyelinating syndromes.","volume":"62","author":"Deiva","year":"2020","journal-title":"Dev. Med. Child Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.neurad.2019.06.001","article-title":"MRI features of demyelinating disease associated with anti-MOG antibodies in adults.","volume":"46","author":"Deneve","year":"2019","journal-title":"J. Neuroradiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1111\/ene.13753","article-title":"Acute idiopathic optic neuritis: not always benign.","volume":"25","author":"Deschamps","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102342","article-title":"Atypical MOG antibody disease presenting with typical multiple sclerosis lesions.","volume":"44","author":"Dolbec","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"B25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jamaneurol.2018.4053","article-title":"Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody.","volume":"76","author":"Dubey","year":"2019","journal-title":"JAMA Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1136\/bjophthalmol-2019-314845","article-title":"MOG-Ab prevalence in optic neuritis and clinical predictive factors for diagnosis.","volume":"104","author":"Ducloyer","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.600169","article-title":"Clinical and radiological features of adult onset bilateral medial frontal cerebral cortical encephalitis with anti-myelin oligodendrocyte glycoprotein antibody.","volume":"11","author":"Fujimori","year":"2020","journal-title":"Front. Neurol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102611","article-title":"Anti-NMDAR encephalitis may develop concurrently with anti-MOG antibody-associated bilateral medial frontal cerebral cortical encephalitis and relapse with elevated CSF IL-6 and CXCL13.","volume":"47","author":"Fujimori","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2019.577002","article-title":"Two Japanese cases of anti-MOG antibody-associated encephalitis that mimicked neuro-Behcet\u2019s disease.","volume":"334","author":"Fujimori","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/jnnp-2016-315094","article-title":"Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies.","volume":"88","author":"Fujimori","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.673472","article-title":"Structural and functional alterations in visual pathway after optic neuritis in MOG antibody disease: a comparative study with AQP4 seropositive NMOSD.","volume":"12","author":"Gao","year":"2021","journal-title":"Front. Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41433-020-01334-8","article-title":"Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disorder-optic neuritis: a comprehensive review of diagnosis and treatment.","volume":"35","author":"Gospe","year":"2021","journal-title":"Eye"},{"key":"B33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1212\/WNL.0000000000004117","article-title":"Diagnostic algorithm for relapsing acquired demyelinating syndromes in children.","volume":"89","author":"Hacohen","year":"2017","journal-title":"Neurology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jamaneurol.2017.3196","article-title":"Seizures and encephalitis in myelin oligodendrocyte glycoprotein IgG disease vs aquaporin 4 IgG disease.","volume":"75","author":"Hamid","year":"2018","journal-title":"JAMA Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1212\/WNL.0000000000004312","article-title":"Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome.","volume":"89","author":"Hennes","year":"2017","journal-title":"Neurology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1177\/1352458514555785","article-title":"Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.","volume":"21","author":"Hoftberger","year":"2015","journal-title":"Mult. Scler."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.","volume":"13","author":"Jarius","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients.","volume":"9","author":"Jarius","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1471-4159.1999.0720001.x","article-title":"The structure and function of myelin oligodendrocyte glycoprotein.","volume":"72","author":"Johns","year":"1999","journal-title":"J. Neurochem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/jnnp-2014-308984","article-title":"Overlapping CNS inflammatory diseases: differentiating features of NMO and MS.","volume":"86","author":"Jurynczyk","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study.","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"key":"B42","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1177\/1352458510390068","article-title":"Disease course and outcome of acute disseminated encephalomyelitis is more severe in adults than in children.","volume":"17","author":"Ketelslegers","year":"2011","journal-title":"Mult. Scler."},{"key":"B43","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s12098-020-03656-7","article-title":"Myelin oligodendrocyte glycoprotein (MOG) antibody disease in a 11 year old with COVID-19 infection.","volume":"88","author":"Khan","year":"2021","journal-title":"Indian J. Pediatr."},{"key":"B44","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000335","article-title":"ADEM-like presentation, anti-MOG antibodies, and MS pathology: two case reports.","volume":"4","author":"Kortvelyessy","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1177\/1352458520951046","article-title":"MOG-IgG1 and co-existence of neuronal autoantibodies.","volume":"27","author":"Kunchok","year":"","journal-title":"Mult. Scler."},{"key":"B47","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1177\/1352458520933884","article-title":"Coexisting systemic and organ-specific autoimmunity in MOG-IgG1-associated disorders versus AQP4-IgG+ NMOSD.","volume":"27","author":"Kunchok","year":"","journal-title":"Mult. Scler."},{"key":"B48","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1212\/WNL.0000000000008786","article-title":"Does area postrema syndrome occur in myelin oligodendrocyte glycoprotein-IgG-associated disorders (MOGAD)?","volume":"94","author":"Kunchok","year":"2020","journal-title":"Neurology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102050","article-title":"MOG antibody associated demyelinating syndrome presenting as aseptic meningitis in a 6-year-old boy.","volume":"41","author":"Leinert","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103030","article-title":"The occurrence of myelin oligodendrocyte glycoprotein antibodies in aquaporin-4-antibody seronegative neuromyelitis optica spectrum disorder: a systematic review and meta-analysis.","volume":"53","author":"Li","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1001\/jamaneurol.2018.1814","article-title":"Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders.","volume":"75","author":"Lopez-Chiriboga","year":"2018","journal-title":"JAMA Neurol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/art.40356","article-title":"Understanding the antibody repertoire in neuropsychiatric systemic lupus erythematosus and neuromyelitis optica spectrum disorder: do they share common targets?","volume":"70","author":"Mader","year":"2018","journal-title":"Arthr. Rheumatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/WCO.0000000000000813","article-title":"Novel insights into pathophysiology and therapeutic possibilities reveal further differences between AQP4-IgG- and MOG-IgG-associated diseases.","volume":"33","author":"Mader","year":"2020","journal-title":"Curr. Opin. Neurol."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.12732","article-title":"Comparison of clinical outcomes of transverse myelitis among adults with myelin oligodendrocyte glycoprotein antibody vs aquaporin-4 antibody disease.","volume":"2","author":"Mariano","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"B55","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/brain\/awaa347","article-title":"Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis.","volume":"144","author":"Mariano","year":"2021","journal-title":"Brain"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1007\/s00415-017-8635-4","article-title":"Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study.","volume":"264","author":"Mariotto","year":"2017","journal-title":"J. Neurol."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.102753","article-title":"Anti-MOG antibody associated encephalomyelitis in an HIV-infected patient.","volume":"49","author":"Mbonde","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102455","article-title":"Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis with considerable white blood cell elevation in cerebrospinal fluid.","volume":"46","author":"Miller","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2021.134","article-title":"FLAIR-hyperintense lesion in Anti-MOG-associated encephalitis with seizures (FLAMES).","author":"Mirian","year":"2021","journal-title":"Can. J. Neurol. Sci."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2019.05.001","article-title":"MOG antibody seropositive aseptic meningitis: a new clinical phenotype.","volume":"333","author":"Nagabushana","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.msard.2017.07.023","article-title":"A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection.","volume":"17","author":"Nakamura","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s10072-020-04822-7","article-title":"Myelin oligodendrocyte glycoprotein-IgG-positive, steroid-responsive combined central and peripheral demyelination with recurrent peripheral neuropathy.","volume":"42","author":"Nakamura","year":"2021","journal-title":"Neurol. Sci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.msard.2018.07.025","article-title":"MOG antibody disease: a review of MOG antibody seropositive neuromyelitis optica spectrum disorder.","volume":"25","author":"Narayan","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"B64","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.msard.2018.10.003","article-title":"Atypical Anti-MOG syndrome with aseptic meningoencephalitis and pseudotumor cerebri-like presentations.","volume":"27","author":"Narayan","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s00415-020-10300-z","article-title":"Myelin oligodendrocyte glycoprotein-antibody-associated disorder: a new inflammatory CNS demyelinating disorder.","volume":"268","author":"Netravathi","year":"2020","journal-title":"J. Neurol."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000322","article-title":"MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy.","volume":"4","author":"Ogawa","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"B67","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/s1474-4422(06)70581-6","article-title":"Sex ratio of multiple sclerosis in Canada: a longitudinal study.","volume":"5","author":"Orton","year":"2006","journal-title":"Lancet Neurol."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3390\/children7110210","article-title":"Acute disseminated encephalomyelitis: current perspectives.","volume":"7","author":"Paolilo","year":"2020","journal-title":"Children"},{"key":"B69","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1006\/clim.1998.4684","article-title":"Experimental autoimmune meningitis: a novel neurological disease in CD28-deficient mice.","volume":"91","author":"Perrin","year":"1999","journal-title":"Clin. Immunol."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.102857","article-title":"MOG-associated encephalitis following SARS-COV-2 infection.","volume":"50","author":"Peters","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"B71","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1212\/WNL.0000000000002825","article-title":"Acute disseminated encephalomyelitis: updates on an inflammatory CNS syndrome.","volume":"87","author":"Pohl","year":"2016","journal-title":"Neurology"},{"key":"B72","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/jnnp-2017-316880","article-title":"Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination.","volume":"89","author":"Ramanathan","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B73","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1177\/1352458515593406","article-title":"Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis.","volume":"22","author":"Ramanathan","year":"2016","journal-title":"Mult. Scler."},{"key":"B74","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrneurol.2013.118","article-title":"The spectrum of MOG autoantibody-associated demyelinating diseases.","volume":"9","author":"Reindl","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000060","article-title":"MOG antibody-associated diseases.","volume":"2","author":"Reindl","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102718","article-title":"Anti-MOG associated disorder-clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience.","volume":"48","author":"Rempe","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000924","article-title":"Overlapping central and peripheral nervous system syndromes in MOG antibody-associated disorders.","volume":"8","author":"Rinaldi","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"B78","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/jim-2019-001126","article-title":"CNS inflammatory demyelinating disorders: MS, NMOSD and MOG antibody associated disease.","volume":"68","author":"Rosenthal","year":"2020","journal-title":"J. Investig. Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1177\/1352458518823486","article-title":"Early predictors of epilepsy and subsequent relapse in children with acute disseminated encephalomyelitis.","volume":"26","author":"Rossor","year":"2020","journal-title":"Mult. Scler."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1177\/1352458519837705","article-title":"MOG antibody-associated encephalomyelitis\/encephalitis.","volume":"25","author":"Salama","year":"2019","journal-title":"Mult. Scler."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1177\/1352458519893093","article-title":"MRI differences between MOG antibody disease and AQP4 NMOSD.","volume":"26","author":"Salama","year":"2020","journal-title":"Mult. Scler."},{"key":"B82","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.","volume":"82","author":"Sato","year":"2014","journal-title":"Neurology"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.499910","article-title":"Differences in advanced magnetic resonance imaging in MOG-IgG and AQP4-IgG seropositive neuromyelitis optica spectrum disorders: a comparative study.","volume":"11","author":"Schmidt","year":"2020","journal-title":"Front. Neurol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/1352458520907900","article-title":"Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies.","volume":"27","author":"Sechi","year":"2021","journal-title":"Mult. Scler."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-020-02041-3","article-title":"Bilateral symmetrical deep gray matter involvement and leptomeningeal enhancement in a child with MOG-IgG-associated encephalomyelitis.","volume":"21","author":"Shen","year":"2021","journal-title":"BMC Neurol."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102013","article-title":"Aseptic meningitis as an atypical manifestation of neuromyelitis optica spectrum disorder flare.","volume":"41","author":"Shi","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"B87","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/ene.14089","article-title":"Clinical, imaging and follow-up study of optic neuritis associated with myelin oligodendrocyte glycoprotein antibody: a multicentre study of 62 adult patients.","volume":"27","author":"Shor","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neurol.2020.06.016","article-title":"MRI characteristics of MOG-Ab associated disease in adults: an update.","volume":"177","author":"Shor","year":"2021","journal-title":"Rev. Neurol."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000257","article-title":"Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis.","volume":"3","author":"Spadaro","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"B90","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.2169\/internalmedicine.2845-19","article-title":"Aseptic meningitis as an initial manifestation of anti-myelin oligodendrocyte glycoprotein antibody-associated disease.","volume":"58","author":"Suzuki","year":"2019","journal-title":"Intern. Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1212\/wnl.59.8.1224","article-title":"Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients.","volume":"59","author":"Tenembaum","year":"2002","journal-title":"Neurology"},{"key":"B92","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1212\/01.wnl.0000259404.51352.7f","article-title":"Acute disseminated encephalomyelitis.","volume":"68","author":"Tenembaum","year":"2007","journal-title":"Neurology"},{"key":"B93","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10072-020-04558-4","article-title":"MOG antibody syndrome presenting as aseptic meningitis: an evolving spectrum.","volume":"42","author":"Vibha","year":"2021","journal-title":"Neurol. Sci."},{"key":"B95","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/ene.13790","article-title":"Encephalitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody associated demyelination: a single-center cohort study in Shanghai, China.","volume":"26","author":"Wang","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.582768","article-title":"The clinical features of FLAIR-hyperintense lesions in anti-MOG antibody associated cerebral cortical encephalitis with seizures: case reports and literature review.","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00401-020-02236-5","article-title":"MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis.","volume":"141","author":"Wildemann","year":"2021","journal-title":"Acta Neuropathol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1007\/s00415-018-9122-2","article-title":"Neurological update: MOG antibody disease.","volume":"266","author":"Wynford-Thomas","year":"2019","journal-title":"J. Neurol."},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.679430","article-title":"The clinical, radiologic, and prognostic differences between pediatric and adult patients with myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis.","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Neurol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1007\/s11427-015-4997-y","article-title":"Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD.","volume":"59","author":"Yan","year":"2016","journal-title":"Sci. China Life Sci."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1007\/s00330-019-06506-z","article-title":"Quantitative brain lesion distribution may distinguish MOG-ab and AQP4-ab neuromyelitis optica spectrum disorders.","volume":"30","author":"Yang","year":"2020","journal-title":"Eur. Radiol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1055\/s-2007-1019130","article-title":"Acute disseminated encephalomyelitis: current understanding and controversies.","volume":"28","author":"Young","year":"2008","journal-title":"Semin. Neurol."},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577519","article-title":"Anti-MOG antibodies associated demyelination following encephalomeningitis: case report.","volume":"353","author":"Zhang","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.671425","article-title":"Case report: myelin oligodendrocyte glycoprotein antibody-associated disorder masquerading as multiple sclerosis: an under-recognized entity?","volume":"12","author":"Zheng","year":"2021","journal-title":"Front. Immunol."},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00415","article-title":"Seizure and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis in a retrospective cohort of chinese patients.","volume":"10","author":"Zhong","year":"2019","journal-title":"Front. Neurol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jocn.2016.12.022","article-title":"Azathioprine therapy in a case of pediatric multiple sclerosis that was seropositive for MOG-IgG.","volume":"38","author":"Zhou","year":"2017","journal-title":"J. Clin. Neurosci."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.850743\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T09:18:07Z","timestamp":1647335887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.850743\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,15]]},"references-count":107,"alternative-id":["10.3389\/fnagi.2022.850743"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2022.850743","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,15]]},"article-number":"850743"}}